Your browser doesn't support javascript.
loading
Novel imidazo[2,1-b]thiazole-based anticancer agents as potential focal adhesion kinase inhibitors: Synthesis, in silico and in vitro evaluation.
Basoglu, Faika; Ulusoy-Güzeldemirci, Nuray; Akalin-Çiftçi, Gülsen; Çetinkaya, Serap; Ece, Abdulilah.
Afiliação
  • Basoglu F; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey.
  • Ulusoy-Güzeldemirci N; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, European University of Lefke, Northern Cyprus, Turkey.
  • Akalin-Çiftçi G; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey.
  • Çetinkaya S; Department of Biochemistry, Faculty of Pharmacy, Anadolu University, Eskisehir, Turkey.
  • Ece A; Department of Molecular Biology and Genetics, Science Faculty, Sivas Cumhuriyet University, Sivas, Turkey.
Chem Biol Drug Des ; 98(2): 270-282, 2021 08.
Article em En | MEDLINE | ID: mdl-34021971

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tiazóis / Inibidores de Proteínas Quinases / Proteína-Tirosina Quinases de Adesão Focal / Imidazóis / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tiazóis / Inibidores de Proteínas Quinases / Proteína-Tirosina Quinases de Adesão Focal / Imidazóis / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article